Related Experiment Video
Updated: Sep 15, 2025

Simple Continuous Glucose Monitoring in Freely Moving Mice
Published on: February 24, 2023
Minimum Continuous Glucose Monitor Data Required to Assess Glycemic Control in Youth with Type 1 Diabetes
Sonia Gera1, Andrew Rearson1, Robert J Gallop2
1Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Approximately 9.6 days of continuous glucose monitor (CGM) data reliably assess glycemia in pediatric type 1 diabetes (T1D). For some youth, 7 days of CGM data may suffice for glycemic assessment.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Pediatric Diabetes Management
Background:
- Continuous Glucose Monitoring (CGM) is crucial for managing type 1 diabetes (T1D).
- Current guidelines recommend 14 days of CGM data for glycemic assessment in T1D.
- Adult studies suggest 7 days of CGM data may be sufficient.
Purpose of the Study:
- To determine the minimum duration of CGM data needed for reliable glycemic assessment in pediatric T1D.
- To evaluate the correlation between shorter CGM data windows and established 14-day metrics.
- To identify factors influencing the required CGM data duration in youth.
Main Methods:
- Real-world Dexcom G6 CGM data from 1316 youth with T1D were analyzed.
- Data from 8 time windows (3-90 days) were compared to 14-day metrics.
- Statistical analyses included Pearson correlation, ICCs, and chi-squared tests.
Main Results:
- Pearson correlation and ICCs between 14-day and other windows exceeded 0.9 for GMI and TIR.
- Categorical agreement for GMI and TIR thresholds reached >90% at 10 days.
- Agreement was stronger for youth with Time in Range (TIR) ≥70% and Coefficient of Variation (CV) <36%.
Conclusions:
- Approximately 9.6 days of CGM data provide a reliable glycemic assessment in pediatric T1D.
- For youth with higher TIR and lower CV, 7 days of CGM data may be adequate.
- This research refines data requirements for pediatric T1D management using CGM.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Hypoglycemia and Glucagon
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...

